 ENGLEWOOD, CO ACCESSWIRE July 27, 2021 Aytu BioPharma, Inc. NASDAQ:AYTU, a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that data from a laboratory study evaluating the ultraviolet A light used in the HealightTM endotracheal catheter technology was published in the peer reviewed journal Photodiagnosis and Photodynamics Therapy. These latest in vitro findings continue to build upon the body of scientific evidence supporting the potential of this UVA platform technology and may help to explain the observed effects of Healight in SARS-CoV-2. 